| 1.71 Data as of 4:00pm ET |  +0.09 / +5.56%Today’s Change | 0.95 Today|||52-Week Range 2.42 | +61.32% Year-to-Date |
| Previous close | 1.62 |
| Today’s open | 1.61 |
| Day’s range | 1.61 - 1.77 |
| Volume | 777,266 |
| Average volume (3 months) | 807,594 |
| Market cap | $91.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +23.73% |
| Earnings growth (this year) | -14.81% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -15.82% |
| P/E ratio | NM |
| Price/Sales | 3.96 |
| Price/Book | 4.25 |
| Today’s change | Today’s % change | |
|---|---|---|
| CPIXCumberland Pharmaceu... | 0.00 | 0.00% |
| DSCODiscovery Laboratori... | +0.05 | +3.01% |
| PRANPrana Biotechnology ... | -0.02 | -0.85% |
| ANTHAnthera Pharmaceutic... | +0.01 | +1.05% |
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $8.7M |
| Annual profit (last year) | -$14.7M |
| Net profit margin | -169.21% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Gil van Bokkelen, PhD |
President, Chief Operating Officer & Secretary William B. J. Lehmann, Jr., MBA |
Corporate headquarters Cleveland, Ohio |
.
